Trials / Completed
CompletedNCT00332007
Tonabersat in the Prophylaxis of Migraine With Aura
A Single Centre, Double-blind, Randomised, Placebo Controlled Crossover Study to Evaluate the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine in Patients Presenting With Migraine With Aura
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Minster Research Ltd · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Overall trial objectives: 1. Can treatment with tonabersat reduce the number of days with aura and/or migraine headache in patients with migraine with aura 2. How well tolerated is treatment with tonabersat The study is based on the hypothesis that the unique mechanism of action of tonabersat will inhibit some of the early events in the generation of aura and migraine headache and so be effective as prophylactic treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tonabersat | two tablets once daily |
| DRUG | Placebo | two tablets once daily |
Timeline
- Start date
- 2006-05-01
- Primary completion
- 2008-08-01
- Completion
- 2008-08-01
- First posted
- 2006-05-31
- Last updated
- 2009-08-31
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00332007. Inclusion in this directory is not an endorsement.